A carregar...
The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial
BACKGROUND AND OBJECTIVES: Uncontrolled secondary hyperparathyroidism (sHPT) in patients with ESRD is a risk factor for calcific uremic arteriolopathy (CUA; calciphylaxis). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Adverse event reports collected during the Evaluation of Cinacalcet HCl Ther...
Na minha lista:
| Publicado no: | Clin J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Nephrology
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4422249/ https://ncbi.nlm.nih.gov/pubmed/25887067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.10221014 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|